US2022106588A1PendingUtilityA1
Dna sequencing using hydrogel beads
Est. expiryFeb 13, 2038(~11.5 yrs left)· nominal 20-yr term from priority
C12Q 2563/159C12Q 2563/149C12Q 2525/191C12Q 1/6874C12N 2330/31C12N 15/1065B01L 7/52B01L 2300/123C12Q 1/6834B01L 2200/16B01L 2200/141C12Q 1/6806B01L 3/508C12N 15/1068
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems, methods, and compositions provided herein relate to preparation of beads encapsulating long DNA fragments for high-throughput spatial indexing. Some embodiments include preparation of nucleic acid libraries within the bead, wherein the bead includes pores that allow diffusion of reagents while retaining genetic material.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A solid support comprising a hydrogel, wherein the hydrogel comprises genetic material, wherein the hydrogel comprises pores that allow diffusion of a reagent through the hydrogel, while retaining the genetic material.
3 . The solid support of claim 2 , wherein the solid support comprises wells, grooves, or patterns.
4 . The solid support of claim 3 , wherein the wells are from about 10 μm to about 50 μm in diameter, and wherein the wells are about 0.5 μm to about 1 μm in depth.
5 . The solid support claim 4 , wherein the wells comprise hydrophobic material comprising an amorphous fluoropolymer.
6 . The solid support of claim 5 , wherein the amorphous fluoropolymer comprises CYTOP, Fluoropel, or Teflon.
7 . The solid support of claim 2 , wherein the genetic material comprises single cell microbes.
8 . The solid support of claim 7 , wherein the microbes are L. gasseri, S. aureus, B. cereus, B. vulgatus, A. baumannii, S. agalactiae , or P. acnes.
9 . The solid support of claim 2 , wherein the reagent comprises enzymes, chemicals, and primers having a size of less than 50 base pairs.
10 . The solid support of claim 2 , wherein the reagent comprises lysozyme, proteinase K, random hexamers, polymerase, transposase, primers, ligase, catalyzing enzyme, deoxynucleotide triphosphates, buffers, or divalent cations.
11 . The solid support of claim 2 , wherein the solid support is functionalized with a surface polymer comprising poly(N-(5-azidoacetamidylpentyl) acrylamide-co-acrylamide) (PAZAM) or silane free acrylamide (SFA).
12 . The solid support of claim 2 , wherein the hydrogel is a hydrogel bead or a hydrogel layer.
13 . The solid support of claim 2 , wherein the hydrogel comprises polyethylene glycol (PEG)-thiol, PEG-acrylate, acrylamide, N,N′-bis(acryloyl)cystamine (BACy), PEG, polypropylene oxide (PPO), polyacrylic acid, poly(hydroxyethyl methacrylate) (PHEMA), poly(methyl methacrylate) (PMMA), poly(N-isopropylacrylamide) (PNIPAAm), poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), polycaprolactone (PCL), poly(vinylsulfonic acid) (PVSA), poly(L-aspartic acid), poly(L-glutamic acid), polylysine, agar, agarose, alginate, heparin, alginate sulfate, dextran sulfate, hyaluronan, pectin, carrageenan, gelatin, chitosan, cellulose, collagen, bisacrylamide, diacrylate, diallylamine, triallylamine, divinyl sulfone, diethyleneglycol diallyl ether, ethyleneglycol diacrylate, polymethyleneglycol diacrylate, polyethyleneglycol diacrylate, trimethylopropoane trimethacrylate, ethoxylated trimethylol triacrylate, or ethoxylated pentaerythritol tetracrylate, or combinations or mixtures thereof.
14 . The solid support of claim 13 , wherein the hydrogel comprises PEG-thiol/PEG-acrylate, acrylamide/N,N′-bis(acryloyl)cystamine (BACy), or PEG/PPO.
15 . A method of identifying single cells, comprising
providing a solid support comprising hydrogel that comprises genetic material of claim 2 , wherein the genetic material comprises single cells; lysing the single cells; amplifying genetic material from the single cells within the hydrogel; performing a tagmentation reaction on the genetic material; and sequencing the genetic material, thereby generating a library encapsulated within the hydrogel.
16 . The method of claim 15 , further comprising performing an amplification reaction on the genetic material encapsulated within the hydrogel prior to performing the tagmentation reaction.
17 . The method of claim 16 , wherein the amplification reaction comprises multiple displacement amplification (MDA).
18 . The method of claim 15 , wherein the tagmentation reaction comprises contacting genetic material with a transposase mixture comprising adapter sequences and transposomes.
19 . The method of claim 15 , further comprising degrading the hydrogel and depositing the library on the solid support.
20 . The method of claim 19 , wherein the hydrogel is degraded by contacting the hydrogel with a cleavage mix or by heating the hydrogel to about 90° C. to release the library.
21 . The method of claim 20 , wherein the cleavage mix comprises dithiothreitol (DTT), tris(2-carboxyethyl)phosphine (TCEP), or tris(3-hydroxypropyl)phosphine (THP).Join the waitlist — get patent alerts
Track US2022106588A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.